Tobacco use disorder is the most common substance use disorder among ind1v1duals with any other psychiatric disorder, resulting 1n enormous health disparities. shorter lifespan. increased suicide risk. and reduced quality of life compared with others. due in part to general medical conditions caused or worsened by tobacc o use. Tobacco use can have financial, employment. relationship. and other personal consequences. Mental health and addiction treatment settings have historically ignored tobacco use; however. psychiatrists and others have recently recognized their crucial role in helping patients to quit. A culture change 1s needed that values addressing tobacco use in behavioral treatment settings to support the integration of evidence-based practices for assessing and treating tobacco use disorder. This clinically focused article provides up-to-date information for practicing psychiatnsts on how to increase screening, assessment. and treatment of tobacco use disorder Clinical tools. such as the carbon monoxide meter. can easily be integrated into practice to assess patients and motivate quitting. Other aids to help patients recover from tobacco use disorder include nicotine replacement therapy med1cat1ons. simple and effective brief psychosocial interventions. and free community resources. Psychiatrists must not only be aware of the changes 1n common psychiatric med1cat1on blood levels that occur when patients change their smoking status but also know the amounts of nicotine in tobacco products, including emerging tobacco products and e-c1garettes. Mounting evidence supports the mental and physical health benefits of quitting tobacco use and the effectiveness of using trad1t1onal tobacco use disorder treatments in helping people with psychiatric disorders quit use.
Tobacco use disorder is the most common substance use disorder among indh-iduals with another psychiatric disorder. Smokers with mental illnes.~ consume 44'Y. of all cig:1rett1:s in the United States (I}, and 50%-95% of patients in mental health and clinical treatment settiJlb'S smoke (2-5). Methadone maintenance pro!,'l'ams and inpatient psychfotry units often have the hit.•hest rates oftohacco use, in the range of75'Y.o-95% (6). Tohacco use increases morhidity and mortality rates :md is the leading prevcntahlc cause of death in the United States. People with serious mental illness die on averahre 25 years earlier than the general population, often because of tobaccorclated diseases (cardiac diseases, pulmonary diseases, and cancers) (7, H). In addition, tobacco use worsens other health conditions, including wound healing, diabetes, impotence, and osteoporosis (9-11). Furthermore, there is a probable independent association between suicide and current smoking :md lont.'t!r lifetime smoking duration (12, 13) . In a recent analysis (14), lollh't!r lifetime smoking (~41 years compared with s lO years) w:1s associated with higher odds of suicide (odd-; ratio-2.26, 95' Y.. confidence intervalr l.30-3.93). It is also ~uggested that snmking cessation can mitig:.1tc the risk (15). Tobacco use c:tn also reduce housing options, discretionary income, and employment and relationship options, and it cnn 290 focus.psych1iltryonlme org Focus 2015 Focus . 13:290-306. doi. 10.1176 increase insurance costs and the stih'llla associated with smoking (16, 17).
CLINICAL CONTEXT FOR ASSESSING AND TREATING TOBACCO USE DISORDERS
Psychiatrists have a t.rreat opportunity to help improve the overall quality of their patients' lives by identi(ving tobacco users in their practice, enhancing motivation to quit, and helping patients with their quit attempts. Historically, many psychiatrists have accepted the belief that they should only address the more immediate pi;ychi:itric problems nnd that quitting tobacco use might worsen a patient's psychi:itric symptom.s. Tobacco's health risks were minimi:l.ed by rationalizing tobacco as a way to self-medicate (lH, 19) . A h'Towing body of literature, including epidemiological studies, invalid:ites the false belief that smoking offers mental health benefits. Contrary to this belief, accming evidence exists that demonstrates suh$tantial improvement in mental health and ()Uality of life as a result of tobacco cessation, especially nmong indh•iduals with a psychiatric or suhstam:c use disorder (20, 21) . Interestingly, evidence also supports the inverse, in which smoking h:1s been linked to a higher likelihood of new-onset 
